Hemosol CEO takes sick leave at critical time for drug firm
Article Abstract:
Hemosol Inc.'s chief executive, John Kennedy, has taken a medical leave of absence from his post. The 45-year old Kennedy will continue his treatment for cancer. However, his absence comes at a critical period for Hemosol.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Lapointe leads ConjuChem comeback
Article Abstract:
The Montreal based drug Development company, ConjuChem Inc's director, Jacques Lapointe's decision to take up the post of director in the company, his future plans for the company and its management is discussed.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Biovail CEO got top executive pay package
Article Abstract:
Biovail Corp.'s chief executive, Eugene Melnyk, received 66.3 million Canadian dollars in salary and stock options profits in the 2002 year. Melnyk led all Canadian executives in terms of their pay packages.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Tories rile auto firms with call for mandatory fuel efficiency. MPs mull not signing bank report
- Abstracts: The Shiite shock wave. Cash from chaos
- Abstracts: Hefty surplus seen up Ottawa's sleeve. Dodge forecasts brighter future. Ottawa, Ontario rev up interest in auto industry
- Abstracts: Record oil prices spark warning of potential for bubble: 'This market is about fear'. Consumers at the wheel of gas price fluctuations: wild cost swings at the pumps are a sore spot for Canadians
- Abstracts: Cinram stakes future on DVDs: Product popularity and U.S. interest fuel firm's growth. DVDs a hit in Canada, especially among Gen Y